FX Conferences is proud to be the leader in providing convenient distance learning opportunities designed for busy professionals. We partner with leading industry experts to bring you key information and guidance on the latest challenges and hot topics, and our audio conference format makes it easy to participate from the office, at home or on the road. Feel free to browse through our list of coming events, or use our search feature to review past live presentations now available as recordings.

Search By
Industry
Department

Risk Management for Medical Devices


Audio conference highlights


Risk Management is vital in medical device design, manufacturing, and post-market surveillance. The FDA QSR requires risk analysis in the design phase, but realizes the need for life cycle management through the complaint system. The FDA recognizes ISO 14971:2007 as a consensus standard. In the European Union, EN ISO 14971:2007 is a harmonized standard and notified bodies will expect full compliance. ISO 13485:2003 also calls out the standard as preferred method.


This audio conference introduces the concepts of Risk Management in ISO 14971:2007. It explains the flow of information from the Risk Management Plan to the Risk Management Report. It covers the differences among Hazard, Harm, and Risk and explains how to evaluate each of them. The program describes development of a Risk Evaluation Matrix taking into account the probability of occurrence and the severity of the harm. The standard requires a list of known and foreseeable hazards as well as foreseeable sequences of events that could result in harm. The presentation describes the tools (FMEA, FTA, and HAACP) and their application.


This audio conference covers:


  • An overview of ISO 14971 to place the presentation in context
  • FDA requirements for risk analysis as part of design validation
  • Recognition status of ISO 14971 by the FDA and for the EU MDD and IVDD
  • The GHTF guidance document on risk management principles
  • Developing a Risk Evaluation Matrix for your product
  • Failure Modes and Effects Analysis (FMEA)
  • Fault Tree Analysis (FTA)
  • Hazard Analysis and Critical Control Point (HACCP)


About the speaker:


Dan O'Leary is President of Ombu Enterprises, LLC, a company offering training and execution in operational excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years of experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and certified by APICS in Resource Management.


Who should attend?


  • Validation Professionals
  • Design Engineers
  • Project Managers involved in Design and Development
  • Quality Engineers assigned to Validation activities
  • Quality Auditors and Managers
  • Quality staff assigned to Customer Complaints or CAPA Management


Product Details

Dan O'Leary, Ombu Enterprises
Risk Management for Medical Devices
Title: President
Duration: 60 minutes
Event Type: Previously recorded on 2011-01-26
Item #: ac20110126b
26 Jan 2011 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 1 review)

Showing 1 Review:

by S.R.
Quality Engineer
Session ran over time which is really not acceptable since it is always possible that an attendee could have a meeting directly afterwards and having the session run over creates a conflict. Aside from that, I thought the content was good. It was a good overview for someone like me who doesn't have much knowledge in this area. However, when I shared certain things after the conference with those in my organization, I was told those things were not true, so I question whether I learned good facts. For example, speaker stated that 'The risk matrix may differ by product. For example, a risk matrix for a heel warmer may not be adequate for an automatic defibrillator.' Several people in my organization said this isn't true. I'm not sure what to believe now. But I still thought the overall seminar was worth attending and i have a much better grasp of harm, hazard, etc.
Rate this item
© Copyright 2012
ForeignExchange Translations.
All rights reserved.

FAQ  |  Medical Translation  |  Search  |  Privacy  |  Terms of Use  |  Contact